{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:45Z","timestamp":1792790505514,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["CR3304"],"award-info":[{"award-number":["CR3304"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e9 de Franche-Comt\u00e9 (CR3300); R\u00e9gion Franche-Comt","id":[{"id":"https:\/\/ror.org\/03pcc9z86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Universit\u00e9 de Franche-Comt\u00e9 CR3300","id":[{"id":"https:\/\/ror.org\/03pcc9z86","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["COVIDCONTROL"],"award-info":[{"award-number":["COVIDCONTROL"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CHU Besan\u00e7on"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in malignant gliomas. EZH2 and Myc play a potential oncogenic role, correlating with the glioma grade. Herewith, we present the first experimental evidence for HCMV as a reprogramming vector, straight through the dedifferentiation of mature human astrocytes, and generation of\n                    <jats:italic>CMV-Elicited Glioblastoma Cells<\/jats:italic>\n                    (CEGBCs) possessing glioblastoma-like traits. HCMV counterparts the progression of the perceived cellular and molecular mechanisms succeeding the transformation and invasion processes with CEGBCs involved in spheroid formation and invasiveness. Glioblastoma multiforme (GBM) biopsies were characterized by an elevated EZH2 and Myc expression, possessing a strong positive correlation between the aforementioned markers in the presence of HCMV. From GBM tissues, we isolated HCMV clinical strains that transformed HAs toward CEGBCs exhibiting upregulated EZH2 and Myc. Spheroids generated from CEGBCs possessed invasion potential and were sensitive to EZH2 inhibitor, ganciclovir, and temozolomide triple therapy. HCMV clinical strains transform HAs and fit with an HCMV-induced glioblastoma model of oncogenesis, and supports the tumorigenic properties of Myc and EZH2 which might be highly pertinent in the pathophysiology of astrocytic brain tumors and thereby paving the way for new therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41388-023-02709-3","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T14:01:52Z","timestamp":1683295312000},"page":"2031-2045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-5870","authenticated-orcid":false,"given":"Ranim","family":"El Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-797X","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Pasquereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-0874","authenticated-orcid":false,"given":"Sandy","family":"Haidar Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Monnien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-0221","authenticated-orcid":false,"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"2709_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ. et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560:243\u20137. https:\/\/doi.org\/10.1038\/s41586-018-0389-3.","journal-title":"Nature"},{"key":"2709_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro-Oncol"},{"key":"2709_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-virology-092818-015907","volume":"6","author":"H zur Hausen","year":"2019","unstructured":"zur Hausen H. Cancers in Humans: A Lifelong Search for Contributions of Infectious Agents, Autobiographic Notes. Annu Rev Virol. 2019;6:1\u201328. https:\/\/doi.org\/10.1146\/annurev-virology-092818-015907.","journal-title":"Annu Rev Virol"},{"key":"2709_CR4","doi-asserted-by":"publisher","first-page":"730765.","DOI":"10.3389\/fimmu.2021.730765","volume":"12","author":"R El Baba","year":"2021","unstructured":"El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From \u201cCanonical\u201d Diseases Toward Virus-Elicited Oncomodulation. Front Immunol. 2021;12:730765. https:\/\/doi.org\/10.3389\/fimmu.2021.730765.","journal-title":"Front Immunol"},{"key":"2709_CR5","doi-asserted-by":"publisher","first-page":"817.","DOI":"10.3390\/v13050817","volume":"13","author":"MR Perera","year":"2021","unstructured":"Perera MR, Wills MR, Sinclair JH. HCMV Antivirals and Strategies to Target the Latent Reservoir. Viruses. 2021;13:817. https:\/\/doi.org\/10.3390\/v13050817.","journal-title":"Viruses"},{"key":"2709_CR6","first-page":"3347","volume":"62","author":"C Cobbs","year":"2002","unstructured":"Cobbs C, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347\u201350.","journal-title":"Cancer Res"},{"key":"2709_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L. et al. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. EBioMedicine. 2018;30:167\u201383. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.015.","journal-title":"EBioMedicine"},{"key":"2709_CR8","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1128\/JVI.00179-16","volume":"90","author":"S Xu","year":"2016","unstructured":"Xu S, Schafer X, Munger J. Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection. J Virol. 2016;90:4346\u201356. https:\/\/doi.org\/10.1128\/JVI.00179-16.","journal-title":"J Virol"},{"key":"2709_CR9","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1128\/JVI.03492-13","volume":"88","author":"J-P Belzile","year":"2014","unstructured":"Belzile J-P, Stark TJ, Yeo GW, Spector DH. Human Cytomegalovirus Infection of Human Embryonic Stem Cell-Derived Primitive Neural Stem Cells Is Restricted at Several Steps but Leads to the Persistence of Viral DNA. J Virol. 2014;88:4021\u201339. https:\/\/doi.org\/10.1128\/JVI.03492-13.","journal-title":"J Virol"},{"key":"2709_CR10","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.1128\/JVI.00676-06","volume":"80","author":"J Odeberg","year":"2006","unstructured":"Odeberg J, Wolmer N, Falci S, Westgren M, Seiger \u00c5, S\u00f6derberg-Naucl\u00e9r C. Human Cytomegalovirus Inhibits Neuronal Differentiation and Induces Apoptosis in Human Neural Precursor Cells. J Virol. 2006;80:8929\u201339. https:\/\/doi.org\/10.1128\/JVI.00676-06.","journal-title":"J Virol"},{"key":"2709_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/373995","volume":"187","author":"T Kossmann","year":"2003","unstructured":"Kossmann T, Morganti\u2010Kossmann MC, Orenstein JM, Britt WJ, Wahl SM, Smith PD. Cytomegalovirus Production by Infected Astrocytes Correlates with Transforming Growth Factor\u2010\u03b2 Release. J INFECT DIS. 2003;187:534\u201341. https:\/\/doi.org\/10.1086\/373995.","journal-title":"J INFECT DIS"},{"key":"2709_CR12","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/JVI.02161-09","volume":"84","author":"MH Luo","year":"2010","unstructured":"Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O\u2019Dowd JM, Fortunato EA. Human Cytomegalovirus Infection Causes Premature and Abnormal Differentiation of Human Neural Progenitor Cells. J Virol. 2010;84:3528\u201341. https:\/\/doi.org\/10.1128\/JVI.02161-09.","journal-title":"J Virol"},{"key":"2709_CR13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.179143","volume":"192","author":"L Geder","year":"1976","unstructured":"Geder L, Lausch R, O\u2019Neill F, Rapp F. Oncogenic Transformation of Human Embryo Lung Cells by Human Cytomegalovirus. Science. 1976;192:1134\u20137. https:\/\/doi.org\/10.1126\/science.179143.","journal-title":"Science"},{"key":"2709_CR14","doi-asserted-by":"publisher","first-page":"408.","DOI":"10.3390\/v10080408","volume":"10","author":"G Herbein","year":"2018","unstructured":"Herbein G. The Human Cytomegalovirus, from Oncomodulation to Oncogenesis. Viruses. 2018;10:408. https:\/\/doi.org\/10.3390\/v10080408.","journal-title":"Viruses"},{"key":"2709_CR15","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1038\/s41388-021-01715-7","volume":"40","author":"Z Nehme","year":"2021","unstructured":"Nehme Z, Pasquereau S, Haidar Ahmad S, Coaquette A, Molimard C, Monnien F. et al. Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus. Oncogene. 2021;40:3030\u201346. https:\/\/doi.org\/10.1038\/s41388-021-01715-7.","journal-title":"Oncogene"},{"key":"2709_CR16","doi-asserted-by":"publisher","first-page":"5051.","DOI":"10.3390\/cancers13205051","volume":"13","author":"I Peredo-Harvey","year":"2021","unstructured":"Peredo-Harvey I, Rahbar A, S\u00f6derberg-Naucl\u00e9r C. Presence of the Human Cytomegalovirus in Glioblastomas\u2014A Systematic Review. Cancers. 2021;13:5051. https:\/\/doi.org\/10.3390\/cancers13205051.","journal-title":"Cancers"},{"key":"2709_CR17","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","volume":"69","author":"M-L Suv\u00e0","year":"2009","unstructured":"Suv\u00e0 M-L, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle J-C. et al. EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance. Cancer Res. 2009;69:9211\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1622.","journal-title":"Cancer Res"},{"key":"2709_CR18","doi-asserted-by":"publisher","first-page":"641.","DOI":"10.3389\/fonc.2019.00641","volume":"9","author":"H Liu","year":"2019","unstructured":"Liu H, Sun Y, Qi X, Gordon RE, O\u2019Brien JA, Yuan H. et al. EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-\u03baB Methylation. Front Oncol. 2019;9:641. https:\/\/doi.org\/10.3389\/fonc.2019.00641.","journal-title":"Front Oncol"},{"key":"2709_CR19","doi-asserted-by":"publisher","first-page":"98348","DOI":"10.18632\/oncotarget.21311","volume":"8","author":"T Yu","year":"2017","unstructured":"Yu T, Wang Y, Hu Q, Wu W, Wu Y, Wei W. et al. The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells. Oncotarget. 2017;8:98348\u201359. https:\/\/doi.org\/10.18632\/oncotarget.21311.","journal-title":"Oncotarget"},{"key":"2709_CR20","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","volume":"112","author":"S Sander","year":"2008","unstructured":"Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TFE. et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008;112:4202\u201312. https:\/\/doi.org\/10.1182\/blood-2008-03-147645.","journal-title":"Blood"},{"key":"2709_CR21","doi-asserted-by":"publisher","first-page":"e1003366.","DOI":"10.1371\/journal.ppat.1003366","volume":"9","author":"CC Rossetto","year":"2013","unstructured":"Rossetto CC, Tarrant-Elorza M, Pari GS. Cis and Trans Acting Factors Involved in Human Cytomegalovirus Experimental and Natural Latent Infection of CD14 (+) Monocytes and CD34 (+) Cells. PLoS Pathog. 2013;9:e1003366. https:\/\/doi.org\/10.1371\/journal.ppat.1003366.","journal-title":"PLoS Pathog"},{"key":"2709_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0252-9","volume":"31","author":"N Ahani","year":"2014","unstructured":"Ahani N, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A. Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues. Med Oncol. 2014;31:252. https:\/\/doi.org\/10.1007\/s12032-014-0252-9.","journal-title":"Med Oncol"},{"key":"2709_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/onc.2013.96","volume":"33","author":"S Zhang","year":"2014","unstructured":"Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene. 2014;33:116\u201328. https:\/\/doi.org\/10.1038\/onc.2013.96.","journal-title":"Oncogene"},{"key":"2709_CR24","doi-asserted-by":"publisher","first-page":"104056.","DOI":"10.1016\/j.ebiom.2022.104056","volume":"80","author":"Z Nehme","year":"2022","unstructured":"Nehme Z, Pasquereau S, Haidar Ahmad S, El Baba R, Herbein G. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus. EBioMedicine. 2022;80:104056. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104056.","journal-title":"EBioMedicine"},{"key":"2709_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5632","volume":"5","author":"D Annibali","year":"2014","unstructured":"Annibali D, Whitfield JR, Favuzzi E, Jauset T, Serrano E, Cuartas I. et al. Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nat Commun. 2014;5:4632. https:\/\/doi.org\/10.1038\/ncomms5632.","journal-title":"Nat Commun"},{"key":"2709_CR26","doi-asserted-by":"publisher","first-page":"e163447.","DOI":"10.1172\/JCI163447","volume":"133","author":"VA Arrieta","year":"2023","unstructured":"Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB. et al. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J Clin Investig. 2023;133:e163447. https:\/\/doi.org\/10.1172\/JCI163447.","journal-title":"J Clin Investig"},{"key":"2709_CR27","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","volume":"80","author":"M-L Eich","year":"2020","unstructured":"Eich M-L, Athar M, Ferguson JE, Varambally S. EZH2-Targeted Therapies in Cancer: Hype or a Reality. Cancer Res. 2020;80:5449\u201358. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2147.","journal-title":"Cancer Res"},{"key":"2709_CR28","doi-asserted-by":"publisher","first-page":"1958.","DOI":"10.3390\/cancers14081958","volume":"14","author":"MR Pantalone","year":"2022","unstructured":"Pantalone MR, Rahbar A, S\u00f6derberg-Naucler C, Stragliotto G. Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma. Cancers. 2022;14:1958. https:\/\/doi.org\/10.3390\/cancers14081958.","journal-title":"Cancers"},{"key":"2709_CR29","doi-asserted-by":"publisher","first-page":"585616.","DOI":"10.3389\/fimmu.2020.585616","volume":"11","author":"T Daubon","year":"2020","unstructured":"Daubon T, Hemadou A, Romero Garmendia I, Saleh M. Glioblastoma Immune Landscape and the Potential of New Immunotherapies. Front Immunol. 2020;11:585616. https:\/\/doi.org\/10.3389\/fimmu.2020.585616.","journal-title":"Front Immunol"},{"key":"2709_CR30","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-0296","volume":"74","author":"A Schuessler","year":"2014","unstructured":"Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K. et al. Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma. Cancer Res. 2014;74:3466\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0296.","journal-title":"Cancer Res"},{"key":"2709_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3934\/mbe.2015011","volume":"13","author":"C Engwer","year":"2016","unstructured":"Engwer C, Knappitsch M, Surulescu C. A multiscale model for glioma spread including cell-tissue interactions and proliferation. Math Biosci Eng. 2016;13:443\u201360. https:\/\/doi.org\/10.3934\/mbe.2015011.","journal-title":"Math Biosci Eng"},{"key":"2709_CR32","doi-asserted-by":"publisher","first-page":"2746.","DOI":"10.3390\/ijms20112746","volume":"20","author":"M Fedele","year":"2019","unstructured":"Fedele M, Cerchia L, Pegoraro S, Sgarra R, Manfioletti G. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma. IJMS. 2019;20:2746. https:\/\/doi.org\/10.3390\/ijms20112746.","journal-title":"IJMS"},{"key":"2709_CR33","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wi\u00dfmann N. et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell. 2022;185:2899\u20132917.e31. https:\/\/doi.org\/10.1016\/j.cell.2022.06.054.","journal-title":"Cell"},{"key":"2709_CR34","doi-asserted-by":"publisher","first-page":"679244.","DOI":"10.3389\/fonc.2021.679244","volume":"11","author":"X Xin","year":"2021","unstructured":"Xin X, Li Q, Fang J, Zhao T. LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers. Front Oncol. 2021;11:679244. https:\/\/doi.org\/10.3389\/fonc.2021.679244.","journal-title":"Front Oncol"},{"key":"2709_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.20517\/cdr.2020.79","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh N, Miner A, Hennis L, Mittal S. Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. CDR. 2021;4:17\u201343. https:\/\/doi.org\/10.20517\/cdr.2020.79.","journal-title":"CDR"},{"key":"2709_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-009-9891-7","volume":"95","author":"JJ Virrey","year":"2009","unstructured":"Virrey JJ, Golden EB, Sivakumar W, Wang W, Pen L, Sch\u00f6nthal AH. et al. Glioma-associated endothelial cells are chemoresistant to temozolomide. J Neurooncol. 2009;95:13\u201322. https:\/\/doi.org\/10.1007\/s11060-009-9891-7.","journal-title":"J Neurooncol"},{"key":"2709_CR37","doi-asserted-by":"publisher","first-page":"4271.","DOI":"10.3390\/cancers14174271","volume":"14","author":"R El Baba","year":"2022","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Diab-Assaf M, Herbein G. Oncogenic and Stemness Signatures of the High-Risk HCMV Strains in Breast Cancer Progression. Cancers. 2022;14:4271. https:\/\/doi.org\/10.3390\/cancers14174271.","journal-title":"Cancers"},{"key":"2709_CR38","doi-asserted-by":"publisher","first-page":"2462.","DOI":"10.3390\/v14112462","volume":"14","author":"G Herbein","year":"2022","unstructured":"Herbein G. High-Risk Oncogenic Human Cytomegalovirus. Viruses. 2022;14:2462. https:\/\/doi.org\/10.3390\/v14112462.","journal-title":"Viruses"},{"key":"2709_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2018.07.004","volume":"53","author":"J Liu","year":"2018","unstructured":"Liu J. The dualistic origin of human tumors. Semin Cancer Biol. 2018;53:1\u201316. https:\/\/doi.org\/10.1016\/j.semcancer.2018.07.004.","journal-title":"Semin Cancer Biol"},{"key":"2709_CR40","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1101\/gad.1596707","volume":"21","author":"FB Furnari","year":"2007","unstructured":"Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683\u2013710. https:\/\/doi.org\/10.1101\/gad.1596707.","journal-title":"Genes Dev"},{"key":"2709_CR41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.neuron.2008.05.031","volume":"58","author":"CD Stiles","year":"2008","unstructured":"Stiles CD, Rowitch DH. Glioma Stem Cells: A Midterm Exam. Neuron. 2008;58:832\u201346. https:\/\/doi.org\/10.1016\/j.neuron.2008.05.031.","journal-title":"Neuron"},{"key":"2709_CR42","doi-asserted-by":"publisher","first-page":"790976.","DOI":"10.3389\/fonc.2022.790976","volume":"12","author":"J Beiriger","year":"2022","unstructured":"Beiriger J, Habib A, Jovanovich N, Kodavali CV, Edwards L, Amankulor N. et al. The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling. Front Oncol. 2022;12:790976. https:\/\/doi.org\/10.3389\/fonc.2022.790976.","journal-title":"Front Oncol"},{"key":"2709_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/cell.2010.0052","volume":"13","author":"F Sher","year":"2011","unstructured":"Sher F, Boddeke E, Copray S. Ezh2 Expression in Astrocytes Induces Their Dedifferentiation Toward Neural Stem Cells. Cell Reprogramming. 2011;13:1\u20136. https:\/\/doi.org\/10.1089\/cell.2010.0052.","journal-title":"Cell Reprogramming"},{"key":"2709_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ajco.12756","volume":"14","author":"AO Sasmita","year":"2018","unstructured":"Sasmita AO, Wong YP, Ling APK. Biomarkers and therapeutic advances in glioblastoma multiforme. Asia-Pac J Clin Oncol. 2018;14:40\u201351. https:\/\/doi.org\/10.1111\/ajco.12756.","journal-title":"Asia-Pac J Clin Oncol"},{"key":"2709_CR45","doi-asserted-by":"publisher","first-page":"7474.","DOI":"10.3390\/ijms23137474","volume":"23","author":"N Senhaji","year":"2022","unstructured":"Senhaji N, Squalli Houssaini A, Lamrabet S, Louati S, Bennis S. Molecular and Circulating Biomarkers in Patients with Glioblastoma. IJMS. 2022;23:7474. https:\/\/doi.org\/10.3390\/ijms23137474.","journal-title":"IJMS"},{"key":"2709_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46014-0","volume":"9","author":"M Guerra-Rebollo","year":"2019","unstructured":"Guerra-Rebollo M, Garrido C, S\u00e1nchez-Cid L, Soler-Botija C, Meca-Cort\u00e9s O, Rubio N. et al. Targeting of replicating CD133 and OCT4\/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure. Sci Rep. 2019;9:9549. https:\/\/doi.org\/10.1038\/s41598-019-46014-0.","journal-title":"Sci Rep"},{"key":"2709_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A. et al. An embryonic stem cell\u2013like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499\u2013507. https:\/\/doi.org\/10.1038\/ng.127.","journal-title":"Nat Genet"},{"key":"2709_CR48","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1073\/pnas.1400283111","volume":"111","author":"Y-W Lou","year":"2014","unstructured":"Lou Y-W, Wang P-Y, Yeh S-C, Chuang P-K, Li S-T, Wu C-Y. et al. Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers. Proc Natl Acad Sci USA. 2014;111:2482\u20137. https:\/\/doi.org\/10.1073\/pnas.1400283111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2709_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-32","volume":"6","author":"R Veselska","year":"2006","unstructured":"Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T. et al. Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer. 2006;6:32. https:\/\/doi.org\/10.1186\/1471-2407-6-32.","journal-title":"BMC Cancer"},{"key":"2709_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/0008-5472.CAN-17-1961","volume":"78","author":"Y Li","year":"2018","unstructured":"Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y. et al. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition. Cancer Res. 2018;78:230\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1961.","journal-title":"Cancer Res"},{"key":"2709_CR51","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1128\/JVI.00188-11","volume":"85","author":"S Kondo","year":"2011","unstructured":"Kondo S, Wakisaka N, Muramatsu M, Zen Y, Endo K, Murono S. et al. Epstein-Barr Virus Latent Membrane Protein 1 Induces Cancer Stem\/Progenitor-Like Cells in Nasopharyngeal Epithelial Cell Lines. J Virol. 2011;85:11255\u201364. https:\/\/doi.org\/10.1128\/JVI.00188-11.","journal-title":"J Virol"},{"key":"2709_CR52","doi-asserted-by":"publisher","first-page":"775194.","DOI":"10.3389\/fsurg.2021.775194","volume":"8","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Yang K, Wang Z, Zhao M, Deng Y, Ji W. et al. CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression. Front Surg. 2022;8:775194. https:\/\/doi.org\/10.3389\/fsurg.2021.775194.","journal-title":"Front Surg"},{"key":"2709_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/noab269","volume":"24","author":"YA Yabo","year":"2022","unstructured":"Yabo YA, Niclou SP, Golebiewska A. Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro-Oncol. 2022;24:669\u201382. https:\/\/doi.org\/10.1093\/neuonc\/noab269.","journal-title":"Neuro-Oncol"},{"key":"2709_CR54","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1158\/0008-5472.CAN-16-0171","volume":"76","author":"F Li","year":"2016","unstructured":"Li F, Liu X, Sampson JH, Bigner DD, Li C-Y. Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors. Cancer Res. 2016;76:5143\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0171.","journal-title":"Cancer Res"},{"key":"2709_CR55","doi-asserted-by":"publisher","first-page":"e52483.","DOI":"10.7554\/eLife.52483","volume":"9","author":"Z Nie","year":"2020","unstructured":"Nie Z, Guo C, Das SK, Chow CC, Batchelor E, Simons SS. et al. Dissecting transcriptional amplification by MYC. ELife. 2020;9:e52483. https:\/\/doi.org\/10.7554\/eLife.52483.","journal-title":"ELife"},{"key":"2709_CR56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1535-7163.MCT-15-0750","volume":"15","author":"X Wu","year":"2016","unstructured":"Wu X, Liu D, Tao D, Xiang W, Xiao X, Wang M. et al. BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer. Mol Cancer Therap. 2016;15:1029\u201342. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0750.","journal-title":"Mol Cancer Therap"},{"key":"2709_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03532-y","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Guo Z-Q, Cao D, Chen Y, Chen J. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1\/FAK\/Akt signaling. Cell Death Dis. 2021;12:244. https:\/\/doi.org\/10.1038\/s41419-021-03532-y.","journal-title":"Cell Death Dis"},{"key":"2709_CR58","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.omtn.2021.03.018","volume":"24","author":"B Yadav","year":"2021","unstructured":"Yadav B, Pal S, Rubstov Y, Goel A, Garg M, Pavlyukov M. et al. LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics. Mol Ther Nucleic Acids. 2021;24:728\u201342. https:\/\/doi.org\/10.1016\/j.omtn.2021.03.018.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2709_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1084\/jem.20120696","volume":"211","author":"Z Ding","year":"2014","unstructured":"Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A. et al. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med. 2014;211:189\u201398. https:\/\/doi.org\/10.1084\/jem.20120696.","journal-title":"J Exp Med"},{"key":"2709_CR60","doi-asserted-by":"publisher","first-page":"1991.","DOI":"10.1167\/iovs.15-18669","volume":"57","author":"S Zhang","year":"2016","unstructured":"Zhang S, Mu Z, He C, Zhou M, Liu D, Zhao X-F. et al. Antiviral Drug Ganciclovir Is a Potent Inhibitor of the Proliferation of M\u00fcller Glia\u2013Derived Progenitors During Zebrafish Retinal Regeneration. Investig Ophthalmol Vis Sci. 2016;57:1991. https:\/\/doi.org\/10.1167\/iovs.15-18669.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2709_CR61","first-page":"6662","volume":"7","author":"T-Y Fan","year":"2014","unstructured":"Fan T-Y, Wang H, Xiang P, Liu Y-W, Li H-Z, Lei B-X, et al. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma. Int J Clin Exp Pathol. 2014;7:6662\u201370.","journal-title":"Int J Clin Exp Pathol"},{"key":"2709_CR62","doi-asserted-by":"publisher","first-page":"772160.","DOI":"10.3389\/fimmu.2021.772160","volume":"12","author":"S Haidar Ahmad","year":"2021","unstructured":"Haidar Ahmad S, Pasquereau S, El Baba R, Nehme Z, Lewandowski C, Herbein G. Distinct Oncogenic Transcriptomes in Human Mammary Epithelial Cells Infected With Cytomegalovirus. Front Immunol. 2021;12:772160. https:\/\/doi.org\/10.3389\/fimmu.2021.772160.","journal-title":"Front Immunol"},{"key":"2709_CR63","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/onc.2016.260","volume":"36","author":"C Battistelli","year":"2017","unstructured":"Battistelli C, Cicchini C, Santangelo L, Tramontano A, Grassi L, Gonzalez FJ. et al. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition. Oncogene. 2017;36:942\u201355. https:\/\/doi.org\/10.1038\/onc.2016.260.","journal-title":"Oncogene"},{"key":"2709_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/noajnl\/vdz029","volume":"1","author":"T Daubon","year":"2019","unstructured":"Daubon T, Guyon J, Raymond A-A, Dartigues B, Rudewicz J, Ezzoukhry Z. et al. The invasive proteome of glioblastoma revealed by laser-capture microdissection. Neuro-Oncol Adv. 2019;1:1\u201312. https:\/\/doi.org\/10.1093\/noajnl\/vdz029.","journal-title":"Neuro-Oncol Adv"},{"key":"2709_CR65","doi-asserted-by":"publisher","first-page":"e60998.","DOI":"10.3791\/60998","volume":"158","author":"J Guyon","year":"2020","unstructured":"Guyon J, Andrique L, Pujol N, R\u00f8sland GV, Recher G, Bikfalvi A. et al. A 3D Spheroid Model for Glioblastoma. JoVE. 2020;158:e60998. https:\/\/doi.org\/10.3791\/60998.","journal-title":"JoVE"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02709-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T06:03:21Z","timestamp":1686290601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02709-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":65,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,6,9]]}},"alternative-id":["2709"],"URL":"https:\/\/doi.org\/10.1038\/s41388-023-02709-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. A written informed consent for participation was obtained from all patients. The study was authorized by the local ethics committees of Besan\u00e7on University Hospital (Besan\u00e7on, France) and the French Research Ministry (AC-2015-2496, CNIL n\u00b01173545, NF-S-138 96900 n\u00b0F2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}}]}}